| Income Statement |
| Operating Expenses | 1.04M |
|
| Research and Development Expense | 254.11K |
| Selling, General and Administrative Expense | 718.75K |
| Operating Income | -1.04M |
| Net Income | 2.27M |
| Net Income Common Stock | 2.27M |
| Net Income Common Stock (USD) | 2.27M |
| Consolidated Income | 2.27M |
| Earnings per Basic Share | 0.01 |
| Earnings per Basic Share (USD) | 0.01 |
| Earnings per Diluted Share | 0.01 |
| Earning Before Interest & Taxes (EBIT) | 2.27M |
| Earning Before Interest & Taxes (USD) | 2.27M |
| Weighted Average Shares | 245.79M |
| Weighted Average Shares Diluted | 248.41M |
| Balance Sheet |
| Cash and Equivalents | 64.69M |
| Cash and Equivalents (USD) | 64.69M |
| Investments | 50.00M |
| Investments Current | 50.00M |
| Current Assets | 115.44M |
| Property, Plant & Equipment Net | 55.38M |
| Total Assets | 170.82M |
| Current Liabilities | 484.96K |
| Total Liabilities | 484.96K |
| Accumulated Retained Earnings (Deficit) | -275.53M |
| Accumulated Other Comprehensive Income | -1.10M |
| Shareholders Equity | 170.34M |
| Shareholders Equity (USD) | 170.34M |
| Assets Non-Current | 55.38M |
| Trade and Non-Trade Payables | 215.40K |
| Cash Flow |
| Net Cash Flow from Financing | 114.23M |
| Net Cash Flow / Change in Cash & Cash Equivalents | 63.34M |
| Issuance (Purchase) of Equity Shares | 118.35M |
| Net Cash Flow from Investing | -50.00M |
| Net Cash Flow - Investment Acquisitions and Disposals | -50.00M |
| Net Cash Flow from Operations | 1.81M |
| Effect of Exchange Rate Changes on Cash | -2.70M |
| Share Based Compensation | 133.32K |